Brokerages Anticipate Safeguard Scientifics, Inc (NYSE:SFE) to Post $1.53 Earnings Per Share

Equities research analysts predict that Safeguard Scientifics, Inc (NYSE:SFE) will post earnings of $1.53 per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics reported earnings per share of ($1.21) in the same quarter last year, which would suggest a positive year-over-year growth rate of 226.4%. The business is expected to announce its next earnings results on Thursday, July 25th.

On average, analysts expect that Safeguard Scientifics will report full year earnings of $1.37 per share for the current financial year. For the next financial year, analysts anticipate that the company will report earnings of ($1.70) per share. Zacks’ EPS calculations are an average based on a survey of analysts that follow Safeguard Scientifics.

Safeguard Scientifics (NYSE:SFE) last announced its quarterly earnings data on Thursday, May 2nd. The asset manager reported $1.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.25.

A number of equities analysts have recently issued reports on SFE shares. Zacks Investment Research downgraded GENEL ENERGY PL/ADR from a “buy” rating to a “hold” rating in a research note on Tuesday, May 7th. ValuEngine raised Zogenix from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 27th.

A number of institutional investors have recently modified their holdings of the stock. Almitas Capital LLC grew its stake in shares of Safeguard Scientifics by 63.5% during the first quarter. Almitas Capital LLC now owns 402,998 shares of the asset manager’s stock valued at $4,373,000 after purchasing an additional 156,580 shares during the last quarter. Yakira Capital Management Inc. grew its position in Safeguard Scientifics by 2.7% during the 1st quarter. Yakira Capital Management Inc. now owns 818,289 shares of the asset manager’s stock valued at $8,878,000 after purchasing an additional 21,600 shares during the last quarter. Salzhauer Michael grew its position in Safeguard Scientifics by 29.1% during the 1st quarter. Salzhauer Michael now owns 20,405 shares of the asset manager’s stock valued at $221,000 after purchasing an additional 4,600 shares during the last quarter. Zeke Capital Advisors LLC purchased a new stake in Safeguard Scientifics during the 1st quarter valued at about $2,212,000. Finally, Cubic Asset Management LLC grew its position in Safeguard Scientifics by 2.6% during the 1st quarter. Cubic Asset Management LLC now owns 82,975 shares of the asset manager’s stock valued at $900,000 after purchasing an additional 2,125 shares during the last quarter. Hedge funds and other institutional investors own 68.28% of the company’s stock.

Shares of SFE stock traded down $0.27 during trading hours on Monday, reaching $11.39. 59,643 shares of the company’s stock were exchanged, compared to its average volume of 66,400. The firm has a market cap of $239.92 million, a P/E ratio of -14.99 and a beta of 0.88. The business’s 50 day simple moving average is $12.11. Safeguard Scientifics has a 1 year low of $7.98 and a 1 year high of $12.91. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.06 and a current ratio of 1.06.

About Safeguard Scientifics

Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.

See Also: Percentage Decliners

Get a free copy of the Zacks research report on Safeguard Scientifics (SFE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.